Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, announces it has acquired the remaining 81 percent equity stake of GQ Bio Therapeutics GmbH for approximately $32 million, net of working capital and other transaction adjustments, to equity holders other than Pacira. The net purchase price includes $18 million of cash paid at closing, $8 million to be paid over three years pursuant to a key employee holdback agreement and a post-closing indemnity holdback of $6 million. The transaction builds upon Pacira’s previous investments in GQ Bio.
Read the full article: Pacira BioSciences Acquires Remaining Equity Stake of GQ Bio //
Source: https://www.globenewswire.com/news-release/2025/02/27/3034262/0/en/Pacira-BioSciences-Acquires-Remaining-Equity-Stake-of-GQ-Bio.html